Education
About Us
Working with TipRanks
Follow Us
Lisa Egbuonu-Davis Insider Profile
4 Followers
Lisa Egbuonu-Davis, Director at Omega Healthcare, holds 25.81K shares in Avanos Medical (Ticker: AVNS), holds 18.14K shares in Phreesia (Ticker: PHR), holds 16.77K shares in Omega Healthcare (Ticker: OHI).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+1.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lisa Egbuonu-Davis holds in companies
Most Profitable Insider Trade
The most profitable trade made by Lisa Egbuonu-Davis
Lisa Egbuonu-Davis's Trading History
Omega Healthcare
Aug 13, 2024
Director
Informative Sell
51.38K
$618.50K
Phreesia
Sep 13, 2024
Director
Informative Sell
32.23K
$429.35K
Avanos Medical
Jan 06, 2025
Director
Uninformative Buy
―
$393.41K
List of latest transactions for each holding click on a transaction to see Lisa Egbuonu-Davis's performance on stock
You May Also Like
Lisa Egbuonu-Davis insider profile FAQ
What is the percentage of profitable transactions made by Lisa Egbuonu-Davis?
The percentage of profitable transactions made by Lisa Egbuonu-Davis is 50%.
What is the average return per transaction made by Lisa Egbuonu-Davis?
The average return per transaction made by Lisa Egbuonu-Davis is 1.30%.
What stocks does Lisa Egbuonu-Davis hold?
Lisa Egbuonu-Davis holds: OHI, PHR, AVNS stocks.
What was Lisa Egbuonu-Davis’s latest transaction?
Lisa Egbuonu-Davis latest transaction was an Uninformative Buy of ―.
What was Lisa Egbuonu-Davis's most profitable transaction?
Lisa Egbuonu-Davis’s most profitable transaction was an Informative Sell of PHR stock on September 13, 2024. The return on the trade was 4.10%.
What is Lisa Egbuonu-Davis's role in Omega Healthcare?
Lisa Egbuonu-Davis's role in Omega Healthcare is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.